Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
RESEARCH TOOLSreports
Total Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$11.43B. The enterprise value is HK$10.61B.
Market CapHK$11.43B
Enterprise ValueHK$10.61B
Share Statistics
Shanghai Haohai Biological Technology Co., Ltd. Class H has 39,141,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,141,840
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Haohai Biological Technology Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 10.95%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)10.95%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee1.24M
Profits Per Employee216.21K
Employee Count2,156
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Shanghai Haohai Biological Technology Co., Ltd. Class H is 13.88. Shanghai Haohai Biological Technology Co., Ltd. Class H’s PEG ratio is -1.39.
PE Ratio13.88
PS Ratio0.00
PB Ratio1.21
Price to Fair Value1.05
Price to FCF70.35
Price to Operating Cash Flow16.91
PEG Ratio-1.39
Income Statement
In the last 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H had revenue of 2.68B and earned 420.45M in profits. Earnings per share was 1.80.
Revenue2.68B
Gross Profit1.87B
Operating Income496.29M
Pretax Income466.14M
Net Income420.45M
EBITDA665.04M
Earnings Per Share (EPS)1.80
Cash Flow
In the last 12 months, operating cash flow was 430.64M and capital expenditures -126.32M, giving a free cash flow of 228.35M billion.
Operating Cash Flow430.64M
Free Cash Flow228.35M
Free Cash Flow per Share5.83
Dividends & Yields
Shanghai Haohai Biological Technology Co., Ltd. Class H pays an annual dividend of HK$1.084, resulting in a dividend yield of 4.55%
Dividend Per ShareHK$1.084
Dividend Yield4.55%
Payout Ratio45.67%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change-15.95%
50-Day Moving Average24.63
200-Day Moving Average27.07
Relative Strength Index (RSI)41.98
Average Volume (3m)756.25K
Important Dates
Shanghai Haohai Biological Technology Co., Ltd. Class H upcoming earnings date is Aug 22, 2025, TBA Not Confirmed.
Last Earnings DateApr 26, 2025
Next Earnings DateAug 22, 2025
Ex-Dividend DateJun 17, 2025
Financial Position
Shanghai Haohai Biological Technology Co., Ltd. Class H as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H has paid 89.90M in taxes.
Income Tax89.90M
Effective Tax Rate0.19
Enterprise Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H EV to EBITDA ratio is 8.77, with an EV/FCF ratio of 0.00.
EV to Sales2.18
EV to EBITDA8.77
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Shanghai Haohai Biological Technology Co., Ltd. Class H has HK$2.69B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -HK$2.69B billion.
Cash & Marketable SecuritiesHK$2.69B
Total Debt¥0.00
Net Cash-HK$2.69B
Net Cash Per Share-HK$68.78
Tangible Book Value Per ShareHK$0.00
Margins
Gross margin is 55.14%, with operating margin of 18.52%, and net profit margin of 15.69%.
Gross Margin55.14%
Operating Margin18.52%
Pretax Margin17.40%
Net Profit Margin15.69%
EBITDA Margin24.82%
EBIT Margin18.07%
Analyst Forecast
The average price target for Shanghai Haohai Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.81%
EPS Growth Forecast-3.79%